1. Home
  2. HY vs CADL Comparison

HY vs CADL Comparison

Compare HY & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyster-Yale Materials Handling Inc.

HY

Hyster-Yale Materials Handling Inc.

HOLD

Current Price

$35.41

Market Cap

684.9M

Sector

Industrials

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.60

Market Cap

551.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HY
CADL
Founded
1991
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
684.9M
551.7M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
HY
CADL
Price
$35.41
$8.60
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.00
AVG Volume (30 Days)
60.3K
2.3M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
3.76%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
$3,769,300,000.00
$125,000.00
Revenue This Year
$1.37
N/A
Revenue Next Year
$5.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.41
$4.35
52 Week High
$44.55
$9.27

Technical Indicators

Market Signals
Indicator
HY
CADL
Relative Strength Index (RSI) 42.65 73.07
Support Level $35.19 $4.80
Resistance Level $38.43 N/A
Average True Range (ATR) 2.05 0.61
MACD -0.51 0.14
Stochastic Oscillator 12.12 83.39

Price Performance

Historical Comparison
HY
CADL

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells, and services a comprehensive line of lift trucks, attachments, aftermarket parts, and technology solutions marketed globally under the Hyster and Yale brand names. The company has four segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni). The majority of its revenue is generated from Lift Trucks. Geographically, it operates in America, EMEA, and JAPIC regions, of which maximum revenue is generated from its business in America, which includes lift truck operations in the U.S., Canada, Mexico, Brazil, and Latin America.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: